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Abstract
Mutations in RNA binding proteins (RBPs) and in genes regulating autophagy are frequent causes of familial
amyotrophic lateral sclerosis (fALS). The P56S mutation in vesicle-associated membrane protein-associated protein B
(VAPB) leads to fALS (ALS8) and spinal muscular atrophy (SMA). While VAPB is primarily involved in the unfolded
protein response (UPR), vesicular trafficking and in initial steps of the autophagy pathway, the effect of mutant P56S-
VAPB on autophagy regulation in connection with RBP homeostasis has not been explored yet. Examining the muscle
biopsy of our index ALS8 patient of European origin revealed globular accumulations of VAPB aggregates co-localised
with autophagy markers LC3 and p62 in partially atrophic and atrophic muscle fibres. In line with this skin fibroblasts
obtained from the same patient showed accumulation of P56S-VAPB aggregates together with LC3 and p62. Detailed
investigations of autophagic flux in cell culture models revealed that P56S-VAPB alters both initial and late steps of the
autophagy pathway. Accordingly, electron microscopy complemented with live cell imaging highlighted the impaired
fusion of accumulated autophagosomes with lysosomes in cells expressing P56S-VAPB. Consistent with these
observations, neuropathological studies of brain and spinal cord of P56S-VAPB transgenic mice revealed signs of
neurodegeneration associated with altered protein quality control and defective autophagy. Autophagy and RBP
homeostasis are interdependent, as demonstrated by the cytoplasmic mis-localisation of several RBPs including pTDP-
43, FUS, Matrin 3 which often sequestered with P56S-VAPB aggregates both in cell culture and in the muscle biopsy of
the ALS8 patient. Further confirming the notion that aggregation of the RBPs proceeds through the stress granule (SG)
pathway, we found persistent G3BP- and TIAR1-positive SGs in P56S-VAPB expressing cells as well as in the ALS8
patient muscle biopsy. We conclude that P56S-VAPB-ALS8 involves a cohesive pathomechanism of aberrant RBP
homeostasis together with dysfunctional autophagy.
Introduction
Amyotrophic lateral sclerosis (ALS) is a devastating
disease characterised by progressive loss of upper and
lower motor neurons (MNs), eventually leading to
paralysis and death. Majority of the fALS- linked genes
either regulate protein quality control and autophagy and/
or RNA binding protein (RBP) homeostasis1,2. Pathogenic
mutations in these genes induce neuronal toxicity coupled
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with protein aggregation, defective proteostasis/autop-
hagy and aberrant RBP homeostasis. However, the factors
that initially triggers these key events and the functional
interplay between autophagy and RBPs homeostasis and
their downstream signalling are poorly understood
thus far.
A dominantly inherited mutation (P56S) in the gene
encoding for the vesicle-associated membrane protein-
associated protein B (VAPB) has been associated with
typical ALS (ALS8), atypical ALS and late-onset spinal
muscular atrophy (SMA)3–5. VAPB is a ubiquitously
expressed membrane-anchored protein of ER and ER-
Golgi intermediate vesicles6,7. VAPB contains an N-
terminal major sperm protein (MSP), a coiled coil and a
transmembrane domain. The MSP domain binds to a
variety of proteins from various cellular compartments
that contain FFAT motifs (two phenylalanines in an acidic
region) and that are known to orchestrate multiple
functions including retrograde transport of proteins6,
lipid transfer toward the Golgi8, regulation of ER structure
through interaction with the microtubule network9,10 and
modulation of responses to ER stress11–13. In line with
this, recent studies have shown that VAPB is involved in
ER-orchestrated autophagosome biogenesis14.
P56S-VAPB forms detergent insoluble cytoplasmic
inclusions, which exhibits toxic gain of functions as
shown by others12,13,15–18 including the detrimental
effects of aggregated P56S-VAPB on protein quality
control, ER-organelle tethering, mitochondrial toxicity,
UPR imbalance and alterations in endo-lysosomal path-
ways11,13,19–21. P56S-VAPB transgenic (Tg) mice under
the control of a pan-neuronal promoter Thy1.2 showed
signs of ER stress in both spinal MNs as well as in CNS
neurons accompanied by a minor degeneration of CNS
neurons22. Lumbar spinal cord α-MNs of these mice can
develop cytoplasmic TDP-43 accumulation23, but showed
only incomplete degeneration accompanied by a mild
motor phenotype at 18 months of age23. In line with this
observation, P56S-VAPB knock-in mice displayed induc-
tion of ER stress and autophagic responses in α-MNs
before obvious onset of behavioural defects24. In addition
to the toxic gain of function P56S-VAPB has been shown
to induce a dominant negative mechanism by incorpor-
ating the normal wild-type (wt) VAPB, supporting a loss
of function hypothesis for ALS8 pathogenesis13,16,17.
Consistent with these data, VAPB knockdown in zebrafish
led to swimming deficits and VAPB knockout mice
showed mild motor deficits associated with autophagy
defects25. Taken together, these results suggest that VAPB
is involved in many functions which are crucial for neu-
ronal survival and that P56S-VAPB alters these processes
involving both toxic gain and/or loss of function. How-
ever, it is still not clear how these pathways are inter-
connected and pathologically orchestrated in ALS8 to
induce neurodegeneration and if and how P56S-VAPB
modulates these converging mechanisms.
To address these issues, we focussed on the effect of
P56S-VAPB on autophagy and RBP homeostasis. We
found that P56S-VAPB-mediated ALS pathology is closely
linked to alterations of both of these interdependent cel-
lular processes. Motor neurons are known to be particu-
larly vulnerable to altered autophagy and RBP
homeostasis1,26–30, explaining why they are selectively
affected by a mutation that is altering these pathways




Fluorescent nucleic acid stain Hoechst 33258 was pur-
chased from Molecular Probes. Thapsigargin, MG132,
Tunicamycin, EGF, Rapamycin, Bafilomycin A, HEPES 4-
(2-hydroxyethyl)-1-piperazineethanesulfonic acid were
purchased from Sigma Aldrich. All primary and second-
ary antibodies and their dilutions used in this study are
listed in Supplementary Table 1. Many of these antibodies
have been used by us in previous published studies (see
references in Supplementary Table 1). Rabbit polyclonal
VAPB antibody was custom made and used by us in
previous studies19,31–33
Human muscle biopsies
Autopsy tissue from P56S-VAPB is not available so far.
We could use archival, formalin-fixed, paraffin-embedded
muscle biopsy materials obtained from an index patient
from European origin with ALS8 due to the P56S-VAPB
mutation5 and stain cryostat sections and resin blocks of
glutaraldehyde-fixed muscle tissue from his mother, who
had shown similar symptoms as her son, but had died
before genetic diagnosis had been available. Muscle
biopsies from clinically confirmed sporadic ALS as well as
age-matched control muscle biopsies were also obtained
from the archives of the Institute of Neuropathology,
RWTH Aachen University Hospital, following the guide-
lines of the Ethics Committee of RWTH Aachen Uni-
versity Hospital (also see below ethical statement).
Experimental animals (P56S-VAPB transgenic mice)
VAPB transgenic mice had been generated using the
cDNAs of wild-type or P56S-mutant human VAPB cloned
into the Thy1.2-expression module. The VAPB constructs
also contained an HA-tag to enable easy visualisation of
transgenic VAPB by immunocytochemical and biochem-
ical approaches. Details of the generation of this trans-
genic mouse are described elsewhere15. In this study we
used tissue from Thy1 wt-VAPB-HA and Thy1 P56S-
VAPB-HA mice at the age around 200 days. Animals were
not randomly assigned during collection, but the strain,
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sex, and age of the mice were the same. We used paraffin
sections of formalin-fixed material from these animals for
most of the histological analyses and fresh frozen tissue
for Western blot analyses. Immunohistochemistry pro-
tocols for formalin-fixed, paraffin-embedded mouse tissue
and all the antibodies used (Supplementary Table 1) were
optimised and performed in analogy to the protocol used
for human biopsy and autopsy tissue to avoid any dis-
crepancies. All procedures including housing and hand-
ling the animals were done in accordance with the
“Principles of laboratory animal care” (NIH publication
No. 86–23) and the guidelines of the Erasmus University
(The Netherlands) animal care committee.
Cell culture, transient transfection and treatments
Cell culture and treatment
Human epithelial cancer cells (HeLa), Human
embryonic kidney cell line (HEK-293), African green
monkey kidney cells (COS-7) and NSC34 motor neuron-
like cells were cultured in Dulbecco’s modified Eagle’s
medium (DMEM, Invitrogen, Carlsbad, CA, USA), sup-
plemented with 10% FBS and 1% antibiotic/anti-mycotic
solution (Invitrogen). Mouse embryonic fibroblasts (MEF)
obtained from the GFP-LC3 transgenic mice34 were also
maintained in DMEM supplemented with 10% FBS and
1% antibiotic/anti-mycotic solution. The human epi-
dermoid carcinoma cell line A431 was grown in Dulbec-
co’s modified Eagle’s medium (DMEM, Invitrogen,
Carlsbad, CA, USA) supplemented with 10% FBS and
0.1% Gentamycin. NIH-3T3 cells stably expressing GFP-
LC3 or tandem mCherry-EGFP-LC3 were cultured in
DMEM supplemented with 10% FBS, 1% penicillin/
streptomycin and puromycin (Sigma Aldrich). Fibroblasts
obtained from P56S-ALS8 fALS patients and healthy
controls were cultured in Dulbecco’s modified Eagle’s
medium (DMEM, Invitrogen, Carlsbad, CA, USA), sup-
plemented with 10% FBS and 1% antibiotic/anti-mycotic
solution (Invitrogen) 20% FBS, 1% penicillin/streptomy-
cin, 1% L-Glutamin and 0.056% amphotericin. Cells were
maintained in a humidified incubator at 37 °C and 5%
CO2. Generation of NIH-3T3 cells stably expressing GFP-
LC3 or tandem mCherry-EGFP-LC3 with retroviral
infection is described elsewhere35.
Human IPSc-derived motor neurons (MNs)
We used iPSCs generated from fibroblasts of a healthy
individual donor (male, age at skin biopsy 34). The gen-
eration and characterisation of the line was previously
described36. For MNs differentiation, we first derived
neural precursor cells (NPCs) which were maintained and
differentiation into MNs as shown previously37. In brief,
NPC were maintained in basic medium (DMEM-F12/
Neurobasal 50:50 medium, N2 Supplement (1:200), B27
Supplement without vitamin A (1:100), penicillin/strep-
tomycin (1%), GlutaMAX (1%)), supplemented with
Chiron 99021 (3 μM), Ascorbic acid (150 μM) and Pur-
morphamine (0.5 μM) on the dishes coated with Matrigel.
For induction of the differentiation into motor neurons,
Scheme 1 Proposed cohesive pathomechanism of aberrant RBPs hoemostasis and autophagy in ALS8. P56S-VAPB aggregates alter early
autophagy proteins ULK1, ATG5-ATG12; late autophagy protein STX17 and leads to the defects in both early and late steps of autophagy. P56S-VAPB
mediated proteotoxic stress together with altered autophagy might contribute to dysregulations of several fALS-associated RBPs (TDP-43, FUS, Matrin
3) including the SGs and can initiate a vicious cycle. (Schematic image was generated with the BioRender software).
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NPC were split on the Matrigel coated dish in the basic
medium supplemented with BDNF (1 ng/ml), Ascorbic
acid (200 μM), Retinoic acid (1 μM), GDNF (1 ng/ml) and
Purmorphamine (0.5 μM) and maintained for 5 days. For
the final maturation, the medium was changed on the day
6 to the basic medium supplemented with DBcAMP
(100 μM), BDNF (2 ng/ml), Ascorbic acid (200 μM),
TGFβ-3 (1 ng/ml) and GDNF (2 ng/ml). Between day 7
and 10 the cells were split onto the dishes coated with
Poly-L-ornithine and laminin and maintained for at least
4–5 weeks before they were used for the final analysis.
The cells were regularly tested for mycoplasma
contamination.
Transient transfections
Cells were transfected to express either GFP-wt-VAPB
or GFP-P56S-VAPB. The detailed description of gen-
eration of these plasmids is given elsewhere31. The
empty pEGFP-N1 vector was used as a transfection
control. All cell lines were transfected using Lipofecta-
mine 2000 reagent (Invitrogen) according to the man-
ufacturer’s recommendations. After 4 h incubation at
37 °C and 5% CO2 the transfection reagent containing
medium was replaced by fresh medium and analysis was
performed 48 h later. IPS-derived MNs were transfected
using NeuroMag reagent (OZ Biosciences) according to
the manufacturer’s protocol; the analysis was performed
after 48 h.
Immunocytochemistry
HeLa, HEK-293, COS-7, MEFs and NIH-3T3 cells were
cultured on µ-dishes (ibidi, GmbH) and transiently
transfected either with GFP-wt-VAPB or P56S-VAPB.
After 48 h cells were fixed in 4% PFA and processed for
confocal microscopy. Permeabilization with 0.5% Triton
X100 and blocking with 4% skimmed milk/normal goat
serum was followed by primary antibody incubation
overnight at 4 °C. Secondary Alexa488- or Alexa594-
conjugated anti-mouse or anti-rabbit antibodies (Invitro-
gen) were used for visualisation. Nuclei were stained with
Hoechst 33258 (1 µg/ml) or were mounted with DAPI
containing fluorescent mounting media (DAKO) and
visualised using a Zeiss LSM 700 confocal microscope
(Zeiss, Oberkochen, Germany). Images were processed
using the Zeiss LSM software and Adobe Photoshop CS5.
Stress granule analysis
FRAP experiments for stress granules analysis on RFP-
G3BP cell lines38,39 overexpressing wt and P56S-VAPB
were performed on a Zeiss LSM710 confocal microscope
(Zeiss, Oberkochen, Germany) equipped with a cell
incubator at 37 °C and 5% CO2. The images were acquired
using a Plan-Apochromat ×63/1.40 Oil DIC M27 objec-
tive and analysed with ZEN 2012 software. For bleaching
90% power of the 561 nm laser (max. 20 mW) was used
with the following capture settings: 380ms per frame and
one image every 600 ms with 10 and 100 frames before
and after bleaching. The bleaching area covered 20 × 20
pixels with a pixel size of 0.1 µm. For all experiments the
bleached area and the duration of the laser impulse were
kept constant. The extent of recovery of the fluorescent
signal was determined using ImageJ to measure the
average pixel intensity values within three distinct regions
of interest: ROI1: bleached area, ROI2: unbleached area
within the cell and ROI3: background. Normalised FRAP
recovery curves and the mobile fraction were calculated
using the programme easy FRAP40.
Live cell imaging to analyse RFP-GFP-LC3 fusion
To analyse the dynamics of the RFP-GFP-LC3 fusion
protein, GFP and RFP channels were acquired every
minute for up to 4 h using the imaging system described
above, see also35. The extent of autophagosome matura-
tion was determined by measuring the co-localisation of
the GFP and RFP signals as expressed by the Pearson’s
coefficient using ZEN software.
Immunoblot analysis
Cells were washed twice with ice-cold PBS and scraped
off the culture plate. After centrifugation at 6000 rpm for
5 min and removal of the supernatant, cell pellets were re-
suspended in lysis buffer (50 mM Tris-Cl, pH8.0, 150mM
NaCl, 1% Triton X-100 in PBS, 0.5 mM PMSF and com-
plete protease inhibitor mixture, Roche Applied Sciences)
and incubated on ice for 30min followed by sonication
with an amplitude of 8% for 10 seconds. Clear lysates were
obtained after centrifugation for 5 min at 6000 rpm. Pro-
tein concentrations were determined using the BCA
method (Molecular Probes). Equal amounts of protein
were boiled for 5 min in 2x SDS sample buffer and sub-
jected to 10 or 12% SDS–PAGE electrophoresis at 20 mA/
gel before being transferred to a polyvinylidenedifluoride
(PVDF) membrane, which had to be activated in methanol
before. Transfer lasted 1 h and 30min at 350mA and was
followed by blocking in 4% skimmed milk in 0.08% Tween
20/Tris-buffered saline (TBS-T) for 30min prior to
incubation with primary antibody. The dilutions for pri-
mary antibodies are described in Supplementary Table 1.
After incubating the primary antibody overnight at 4 °C
under gently shaking, membranes were washed three
times with TBS-T for 10min each and incubated with the
appropriate horseradish peroxidase-conjugated secondary
antibody for 1 h (antibody dilution 1:10,000) followed by
the same washing procedure. Immunoreactive proteins
were detected by enhanced chemiluminescence (Amer-
sham Biosciences). Densitometric quantification of the
band intensity was normalised to tubulin levels using
Adobe Photoshop CS5.
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EGFR endocytosis, starvation and degradation assay
For EGFR endocytosis and degradation analysis,
A431 cells were starved in DMEM without serum for 4 h.
After starvation, cells were treated with EGF (100mg/ml)
to stimulate EGFR endocytosis. Cells were then collected
at various time points and lysed in RIPA buffer (50 mM
Tris–HCl pH 7.5, 1% Triton X-100, 150mM NaCl, 1 mM
EDTA and 0.1% Na deoxycholate) containing protease
inhibitor. Protein extracts were resolved by SDS–PAGE
and immunoblotted using anti-EGFR antibody.
EGFR surface biotinylation assay
Surface biotinylation assays were performed as pre-
viously described35 with minor modifications. Briefly,
transfected A431 cells were starved in DMEM without
serum for 4 h. After starvation, cells were treated with
EGF to stimulate EGFR endocytosis and then preceded
for surface biotinylation assays according to the manu-
facturer’s protocol.
Subcellular fractionation
The subcellular distributions of distinct proteins were
determined by using a subcellular fractionation kit fol-
lowing the manufacturer’s protocol (Thermo Scientific/
Life Technologies) and analysed by immunoblotting. The
subcellular fractionation was performed on HeLa cells as




In all, 3–4-µm paraffin sections were placed on poly-L-
lysine coated slides and allowed to dry in an oven (37 °C)
overnight and then processed for immunohistochemistry
described in detail elsewhere32. Sections deparaffinized in
xylene for 20min were rehydrated in 100%, 95% and 70%
ethanol for 5 min each followed by endogenous perox-
idase quenching (0.3% H2O2 in methanol) for 20 min. For
antigen retrieval, sections were heated in citrate buffer,
pH 6 (DAKO), for 20min in a pressure cooker. After
washing in PBS, sections were incubated with primary
antibody (Supplementary Table 1) for 1 h at room tem-
perature or at 4 °C overnight. After washing in PBS, sec-
tions were incubated with appropriate polymeric HRP-
linker secondary antibody (IL Immunologic, Duiven, The
Netherlands) for 30 min at room temperature. Diamino-
benzidine (DAB) reagent (DCS Innovative Diagnostic
System DAB kit) was used to stain the sections which
were then counter-stained with 6% hematoxylin for 3 min.
All procedures were performed at room temperature.
Standard histological and histochemical stains including
H&E, modified Gomori trichrome, non-specific esterase
and NADH were performed as described by us and others
previously41.
Immunofluorescence
Single and double immunofluorescence staining was
performed as described by us already elsewhere32,42. In
brief, deparaffinized tissue sections were heated in citrate
buffer, pH 6 (Dako), for 20 min in a pressure cooker.
Sections were then blocked (to avoid non-specific bind-
ings) with ready to use 10% normal goat serum (Life
Technologies, MD, USA) for 1 h at room temperature
before incubating with primary antibody at 4 °C overnight.
After washing in TBS-T for 10min, the sections were
incubated with Alexa conjugated secondary antibody (1 :
500 in TBS-T) at room temperature for 2 h. Sections were
washed in TBS-T (2 × 10min) and stained for 10min with
0.1% Sudan Black in 80% ethanol to suppress endogenous
lipofuscin auto-fluorescence. Finally, the sections were
washed for 5 min in TBST and mounted with Vectashield
mounting medium (Vector Laboratories)
containing DAPI.
Transmission electron microscopy (TEM)
NSC-34 cells were transfected with pEGFP-N1, GFP-
wt-VAPB or P56S-VAPB as described above. Cells were
collected by scraping and then washed in 0.1M phosphate
buffer and immediately fixed with 2.5% glutaraldehyde in
0.1M phosphate buffer for 24 h followed by washing in
buffer for another 24 h. Cell pellets were collected by
centrifugation (1000 rpm, 5 min) and embedded in 2%
agarose (at 60 °C; Fluka # 05073). Small blocks of
embedded cells were sliced and post-fixed in 2.5% glu-
taraldehyde for 24 h followed by washing in 0.1M phos-
phate buffer for 24 h. Agarose blocks were then incubated
in 1% OsO4 (in 0.2M phosphate buffer) for 3 h, washed
twice in distilled water and dehydrated using ascending
alcohol concentrations (i.e. 25%, 35%, 50%, 70%, 85%,
95%, 100%; each step for 5 min). Dehydrated blocks were
incubated in propylenoxide followed by subsequent
20min incubation in a 1:1 mixture of epon (47.5% glyci-
dether, 26.5% dodenylsuccinic acid anhydride, 24.5%
methylnadic anhydride and 1.5% Tris (dimethylamino-
methyl) phenol) and propylenoxide. The samples were
then incubated in epoxy resin for 1 h at room temperature
followed by polymerisation (28 °C for 8 h, 80 °C for 2.5 h
and finally at room temperature for 4 h). Ultra-thin sec-
tions (70 nm) were mounted on grids for electron
microscopy and examined using a Philips CM10 trans-
mission electron microscope as already described19.
Image acquisition
Images of the DAB-stained sections were taken with a
Zeiss Axioplan microscope equipped with a 40x objective
and an Axio Cam 506 color camera (Zeiss). Images from
immunofluorescence labelled sections were taken with a
Zeiss LSM 700 laser scanning confocal microscope using
×20, ×40 and ×63 objectives. Images were acquired by
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averaging 4 scans per area of interest resulting in an image
size of 1024 × 1024 pixels. The laser intensity was kept
constant for all the samples examined. Captured confocal
images were analysed using Adobe Photoshop CS5 and
ZEN (Blue edition) 2009 software.
Statistical analysis
We used one-way ANOVA for comparison of multiple
groups within individual experiments and also applied
unpaired Student’s t test for comparison between two
sample groups for the evaluation of significant differences
using Graph pad Prism software. Values were expressed
as mean ± standard error of mean (SEM) from three
independent experiments. For the FRAP and co-
localisation experiments, we used the Mann–Whitney U
test. For both statistical tests, differences between the
compared experimental conditions were regarded as sig-
nificant when *P < 0.05, ***P < 0.0001, while # denotes
absence of a significant difference. For the quantification
of numbers of autophagosomes (Fig. 2h), large,
membrane-bound autophagosomes, filled with the car-
goes were counted manually from EM images for 20–30
cells from both wt-VAPB as well as P56S-VAPB cells.
Sample sizes of all experiments were determined based
upon our experience. No sample was excluded from the
analyses. Animals were carefully assigned during collec-
tion not randomly, based upon same strain, sex, and age.
The replicates numbers are indicated in each figure
legend.
Results
P56S-VAPB leads to defective autophagy in ALS8
Over expressed P56S-VAPB forms ER-associated
aggregates in cells, hiPSC MNs (Supplementary Fig. 1a,
b) as well as in the P56S-VAPB transgenic mouse models
(Supplementary Fig. 1c); in contrast, P56S-VAPB inclu-
sions were absent in induced pluripotent stem cell (iPSC)-
derived MNs of ALS8 patients43. Autopsy tissues from
ALS8 patients are not available so far to address the toxic
gain of function of P56S-VAPB, however, for current
study, we could use muscle biopsies obtained from an
index ALS8 patient of European origin5 and from his
affected mother. H&E staining of the index patients’
muscle biopsy and the routine histology from his affected
mother showed severe neurogenic grouped fibre atrophy
(Fig. 1a and Supplementary Fig. 1d), associated with
increased immunoreactivity for several ER chaperones
and proteotoxicity markers (Supplementary Fig. 1e) in
partially atrophic and atrophic muscle fibres of the index
patient.
Using our custom made VAPB antisera31–33, we found
accumulation of globular aggregates of VAPB in dener-
vated muscle fibres (Fig. 1b, arrowheads). Normal-sized
innervated muscle fibres in this biopsy as well as control
biopsies showed mild to moderate sarcoplasmic VAPB
immunoreactivity (Fig. 1b). Skin fibroblasts obtained from
this ALS8 patient revealed smaller prominent punctate
VAPB aggregates (Fig. 1c), which formed larger globular
aggregates when challenged with proteasome or autop-
hagy inhibitors (Fig. 1c; arrowheads right panel). Western
blot analysis confirmed the presence of SDS-insoluble gel
top VAPB aggregates in ALS8 fibroblast (Supplementary
Fig. 1f)
Since VAPB protein is crucial for autophagy14,20, we
used the ALS8 muscle biopsy and the patient-derived
fibroblasts to understand if aggregated P56S-VAPB affects
the autophagy pathway.
DAB immunohistochemistry using antibodies against
autophagic markers LC3 and p62 revealed their accu-
mulations in degenerating fibres containing large autop-
hagic vacuoles (Fig. 1d; arrows). Immunofluorescence
showed even more prominent accumulations of large LC3
and p62 puncta, which were specifically co-localised with
globular VAPB aggregates (Fig. 1e). Consistent with these
findings, ALS8 fibroblasts also showed co-localisation of
accumulated LC3 and p62 together with P56S-VAPB
aggregates (Fig. 1f; arrowheads).
P56S-VAPB aggregates sequestering both LC3 and p62
were indicative of altered autophagy. Thus we next ana-
lysed the autophagy status in several cell lines expressing
P56S-VAPB tagged with GFP following current guide-
lines44–47. Western blot analysis showed LC3 II and p62
were elevated together with the ER stress markers GRP78
both in P56S-VAPB transfected cells (Fig. 1g and Sup-
plementary Fig. 1g) and in ALS8 fibroblasts (Supple-
mentary Fig. 1f). Interestingly, consistent with the
appearance of SDS insoluble VAPB smears (black
arrowhead, Fig. 1g) in P56S-VAPB expressing cells, p62
protein was also aggregated at the gel top (red arrowhead,
Fig. 1g). In line with this LC3 and p62 positive autopha-
gosomes were found to be abnormally accumulated and
sequestered with P56S-VAPB aggregates (Fig. 1h, i and
Supplementary Fig. 1h, i). Similarly, a consistent pattern
of accumulated LC3 by immunofluorescence analysis
(Fig. 1j), confirmed by Western blot studies (Fig. 1k) was
observed in NIH3T3 fibroblasts stably expressing GFP-
LC335,42. Furthermore, we applied a widely used method
to analyse the internalization and degradation of the EGF-
EGFR complex in A431 cells that express high EGFR
levels which is exclusively degraded via autophagy35,42,48.
Here again, expression of P56S-VAPB led to the accu-
mulations of EGFR together with p62 and LC3 (Fig. 1l).
The expression of wt or P56S- VAPB did not impair
EGFR internalization after 10 min of EGF stimulation (not
shown). However, P56S-VAPB, in contrast to wt-VAPB,
impeded time-dependent degradation of EGFR (Fig. 1m).
Defective autophagy was further characterised by ultra-
structural analysis of P56S-VAPB-transfected cells,
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showing prominent accumulations of numerous autop-
hagic vacuoles (white arrows) which also sequestered
cellular components/cargoes (Fig. 1n). These changes
were accompanied by the cytoplasmic accumulation of
tubular structures (black arrow), probably reflecting ER
proliferation (Fig. 1n).
P56S-VAPB alters both early and late steps of autophagy
Aggregated p62 at the gel top, co-localisation of LC3
and p62 with P56S-VAPB aggregates and increased LC3-
II in Western blots (Fig. 1) were all indicative of blocked
autophagic flux. However, to further rule out that these
effects were not due to increased autophagic activity, we
next systematically monitored autophagic flux45,47.
Compromised degradation of accumulated LC3II due to
P56S-VAPB was confirmed by Western blot analysis in
NSC-34 cells, where autophagy induction (Rapamycin) or
inhibition (Bafilomycin A) only marginally, if at all,
affected p62 and LC3-II levels in P56S-VAPB expressing
cells compared to wt-VAPB (Fig. 2a). Consistently in
GFP-LC3 reporter lines and in primary mouse embryonic
fibroblasts, the absence of a significant increase in LC3-II
and p62 protein levels even after Bafilomycin A treatment
(Fig. 2b, c) further confirmed impaired clearance of
accumulated autophagosomes.
A possible scenario underlying the above phenomenon
might be the fusion defects of autophagosomes to lyso-
somes in P56S-VAPB expressing cells. To test this pos-
sibility, we monitored the fusion of autophagosomes to
lysosomes using previously described NIH3T3- mCherry-
GFP-LC3 cells49. As the GFP signal is lost upon degra-
dation in the acidic environment of lysosomes, loss of
GFP signal relative to mCherry signal is a read out of
autophagosome fusion with lysosomes49. Consistent with
this notion, live cell imaging showed that GFP signal was
relatively preserved in mCherry-GFP-LC3 cells that also
expressed P56S-VAPB, suggesting that the fusion of
autophagosomes with lysosomes was impaired by P56S-
VAPB (Fig. 2d, e). In contrast, we observed both a clear
reduction of GFP fluorescence and RFP-GFP co-localisa-
tion in nearly all wt-VAPB expressing cells (Fig. 2d, e). To
further support this conclusion, we analysed the SNARE
protein syntaxin 17 (STX17) which is essential for the
fusion of lipid bilayers and required for autophagosome-
lysosome fusion50. Using Immunofluorescence analysis,
we observed that STX17 protein immunolabelling were
(see figure on previous page)
Fig. 1 P56S-VAPB leads to defective autophagy in ALS8. a Representative H&E stained section from ALS8 index patient muscle biopsy showing
typical neurogenic atrophy; presence of angular, flatten and group fibre atrophy. Scale bar: 60 µm. b Prominent immunoreactivity of globular VAPB
aggregates (arrowheads, right panels) in grouped angular or flattened, atrophic, denervated muscle fibres of ALS8 compared to the normal control
(left panel) showing diffuse pattern of sarcomeric VAPB immunolabelling in normal-sized fibres. Scale bars: 70 µm. c Immunolabeling of human
fibroblasts using VAPB antibody showing small but enormous punctate P56S-VAPB aggregates in ALS8 fibroblast (right panel, white arrowheads),
compared to control (left panel). Note the increased formation of globular P56S-VAPB aggregates (arrowheads) in ALS8 fibroblasts, after treatment
with proteasome inhibitor MG132 (2 µM) and Bafilomycin A (200 nM) for 4 h. Scale bars: 10 µm. d DAB immunohistochemistry performed on ALS8
muscle biopsy showing increased accumulation of autophagy marker p62 and LC3 in atrophic and partially atrophic fibres. Note the numerous large
autophagic vacuoles (white arrows) present in hypertrophic fibres. Scale bars: 50 µm. e Double immunofluorescence labelling of ALS8 muscle biopsy
using antibodies against VAPB and for the autophagy marker p62 and LC3 showing co-localisation of the aggregated p62 and LC3 together with the
mutant VAPB aggregates. Scale bars: 25 µm. f Punctate P56S-VAPB aggregates co-localised with LC3 and p62 accumulations in ALS8 fibroblasts. Scale
bars: 10 µm. g Immunoblot analysis in NSC-34 cells transiently transfected either with empty GFP vector, wt-VAPB and P56S-VAPB. Note the increased
levels of ER stress, autophagy markers as well as presence of gel top smear aggregate of P56S-VAPB (black arrowhead) and aggregated p62 (red
arrowhead) in P56S-VAPB expressing cells. Corresponding densitometric data are shown at the bottom; representing the relative band intensity of
LC3-II/LC3-I, normalised with tubulin levels. Graph pad prism, unpaired Student’s t test for comparison between two sample groups. Values were
expressed as mean ± standard error of mean (SEM) from three independent experiments. The asterisks denote significant differences (*p < 0.05).
h, i Co-labelling of wt-VAPB and P56S-VAPB with LC3 (h) and with p62 (i). Note that the globular accumulations of both LC3 and p62 and their co-
localisation with P56S aggregates. Scale bar: 10 µm. j, k Increased accumulation of autophagosomes (white arrowheads) in the stable autophagy
reporter cell line NIH3T3-GFP transfected with P56S-VAPB. Green: GFP-LC3; red: VAPB; scale bar: 10 µm (j). Immunoblot analysis showing increased
levels of both p62 and LC3 in cells transfected with P56S-VAPB (k). Unpaired Student’s t test for comparison between two sample groups. Values were
expressed as mean ± standard error of mean (SEM) from three independent experiments. The asterisks denote significant differences (*p < 0.05).
l Immunoblot analysis of A431 cells transfected with EGFP, wt-VAPB and P56S-VAPB showing the increased levels of the autophagy markers EGFR,
p62 and LC3 in P56S-VAPB expressing cells. Unpaired Student’s t-test for comparison between two sample groups. Values were expressed as mean ±
standard error of mean (SEM) from three independent experiments. The asterisks denote significant differences (*p < 0.05). m A431 cells were
transfected as described above. 24 h later, transfected cells were processed for the EGFR degradation assay (see Methods) and analysed by
immunoblotting with the EGFR antibody. Note the delayed EGFR degradation in P56S-VAPB expressing cells. Right panel: quantification of
immunoblots analysis. Graph pad prism, unpaired Student’s t test for comparison between two sample groups. Values were expressed as mean ±
standard error of mean (SEM) from three independent experiments. The asterisks denote significant differences (*p < 0.05), while # denotes absence
of a significant difference. n NSC-34 cells overexpressing wt-VAPB and P56S-VAPB were fixed with 2.5% buffered glutaraldehyde and processed for
EM. Several membrane-bound vacuolar structures (white arrows) often containing cargoes and probably derived from the ER in a representative
P56S-VAPB-expressing cell compared to cells expressing wt-VAPB control. Higher magnification showing the ER membrane proliferation into tubular
structures (black arrow; lower left panel), and large autophagic vacuoles often filled with cargoes (white arrow; lower panel) in representative P56S-
VAPB expressing cells. Scale bars: 1 µm (upper panel), 0.5 µm (lower panel).
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markedly reduced in HEK-293 as well as in HeLa cells
harbouring P56S-VAPB aggregates (Fig. 2f, arrows).
Consistent with this findings Western blot analysis of the
above cell lysates showed a significant decrease in STX17
protein levels in P56S-VAPB overexpressing cells com-
pared to the wt-VAPB and control GFP overexpressing
cells (Fig. 2g, quantification below).
Finally, electron microscopy performed on NSC-34 cells
revealed that, consistent with impaired fusion, massive
accumulation of autophagosomes with cargoes (white
arrows) were found in the vicinity of lysosomes (black
arrows), indicative of impairment of their fusion (Fig. 2h,
quantification of the accumulated autophagosomes).
Taken together, our findings demonstrate that P56S-
VAPB impairs the autophagic degradation due to
incomplete clearance of autophagosomes (i.e., late-stage
autophagy).
Recently, Zhao et al. reported that P56S-VAPB muta-
tion reduces the ULK1/FIP200 interaction and impairs
autophagy at an early stage, namely autophagosome bio-
genesis14. Therefore, as a next logical step, we also ana-
lysed the effect of P56S-VAPB on early steps of
autophagy. We focussed on ULK1 as well as on ATG5-
ATG12, because the ATG5- ATG12 containing complex
is essential for membrane expansion and completion of
the autophagosome51–53
While both ULK1 and ATG5-ATG12 proteins were
distributed throughout the cell, largely co-distributing
with wt-VAPB (Fig. 3a, b); however, they both sequestered
with P56S-VAPB aggregates in P56S-VAPB expressing
cells (Fig. 3a, b arrows). Filter trap assays further confirms
the presence of SDS resistant aggregates of both of these
proteins in P56S-VAPB expressing cells (Fig. 3c). Con-
sistent with this, Western blots indicated that ULK1
protein levels were elevated in wt-VAPB expressing cells
(Fig. 3d), whereas in P56S-VAPB expressing cells, frac-
tions of ULK1 protein remained at the gel-top as an
aggregated form (Fig. 3d, e; red arrowhead), thus resulting
in reduced amounts of its soluble form (Fig. 3d, e). Similar
to ULK1 and consistent with the filter trap assay, ATG5-
ATG12 protein complex (actual molecular weight=
55 kDa) was also found to be aggregated at the gel-top
(Fig. 3d). Even though such alterations of crucial
autophagy-associated proteins are consistent with defects
in early phases of autophagy14; increased levels of LC3-II
in the same samples (Fig. 3d, e) together with our earlier
observations (Fig. 2) suggest defects in late-stage autop-
hagy. We used multiple cell lines expressing either the wt
or P56S-VAPB (Figs. 2, 3d–g, and Supplementary Fig. 1j)
and in most of them P56S-VAPB induced both the
reduction of soluble form / aggregation of ULK1 at the gel
top as well as increased levels of p62/LC3-II. Based on
these observations, we concluded that P56S-VAPB alters
both late and early steps of autophagy simultaneously.
Autophagy defects in P56S-VAPB transgenic mice
Prompted by the above findings we next examined
autophagy markers in transgenic mice expressing P56S-
mutant human VAPB that develop VAPB aggregates both
in lumbar spinal cord α-MNs as well as in cortical neu-
rons accompanied by ER stress15,22 (Fig. 4a and Supple-
mentary Fig. 2c–f). Both lumbar spinal cord α-MNs
(Fig. 4b, c) and cortical neurons (Supplementary Fig. 2e)
consistently showed co-localisation of LC3 and p62
together with globular P56S-VAPB aggregates. In line
with the above observations in cell culture models (Figs. 2
and 3), we also found significantly reduced immunor-
eactivity of STX17 (Fig. 4e) and sequestration of early
(see figure on previous page)
Fig. 2 P56S-VAPB alters late step of autophagy. a–c Immunoblot analysis of transiently transfected control GFP/RFP, wt-VAPB and P56S-VAPB; in
NSC-34 cells (a), NIH3T3-GFP-LC3 fibroblasts (b) and of the Primary fibroblasts isolated from autophagy reporter GFP-LC3 transgenic mice (MEF-GFP-
LC3) (c), and then additionally treated with the autophagy inhibitor Bafilomycin A (2 µM) for 2 h to inhibit autophagy followed by treatment of
Rapamycin (2 µM) for 4 h to accelerate autophagy (a) or Bafilomycin A (2 µM) alone (b, c). Note the unchanged LC3-II levels in P56S-VAPB transfected
cells after Rapamycin or Bafilomycin A treatment. Corresponding densitometric data are shown at the bottom; where the numbers represent the
relative band intensity of LC3-II/LC3-I, normalised with tubulin levels. Graph pad prism, unpaired Student’s t test for comparison between two sample
groups. Values were expressed as mean ± standard error of mean (SEM) from three independent experiments. The asterisks denote significant
differences (*p < 0.05, ***p < 0.001), while # denotes absence of a significant difference. d, e NIH3T3 fibroblasts stably expressing RFP-GFP-LC3 was
transfected either with HA tagged wt-VAPB or P56S-VAPB. In all, 24 h later the fusion of autophagosomes with lysosomes was measured by live cell
imaging for additional 12 h (d), the rate of autophagosome fusion reflected by the Pearson coefficient (green/red fluorescence ratio) at each time
point indicated (e). Values are represented as means ± S.E.M. of triplicate experiments *p≪ 0.0001. f Co-labelling of wt-VAPB and P56S-VAPB
transfected HEK-293 as well as HeLa cells with STX17, showing its marked reduction (arrows) in cells harbouring P56S-VAPB aggregates. Scale bar:
10 µm. g Immunoblot analysis of STX17 proteins in HEK-293 as well as HeLa cells, transiently transfected with control GFP, wt-VAPB and P56S-VAPB.
Note the significantly reduced levels of STX17 in P56S-VAPB overexpressing cells. Unpaired Student’s t test for comparison between two sample
groups. Values were expressed as mean ± standard error of mean (SEM) from three independent experiments. The asterisks denote significant
differences (*p < 0.05). h EM analysis of P56S-VAPB transfected NSC-34 cells showing massive accumulation of autophagosomes (white arrows,
quantification) in the vicinity of several lysosomes (black arrows). For the quantification of autophagosomes, numbers of large, membrane-bound
autophagosomes, filled with the cargoes were counted manually from 20 to 30 cells from both the wt-VAPB as well as P56S-VAPB. The asterisks
denote significant differences (***p < 0.001). Scale bars: 1 µm.
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autophagy proteins ULK1, ATG5-ATG12 together with
the globular P56S-VAPB aggregates in the lumbar spinal
cord α-MNs of P56S-VAPB mice (Fig. 4f, g). Consistent
with this, Western blot analysis of lumbar spinal cord
lysates and the total brain lysates revealed increased levels
of p62 as well as LC3 together with markedly increased
UPR (Fig. 4d and Supplementary Fig. 2h). Interestingly,
here again p62 appeared as SDS-insoluble aggregates at
the gel-top in the immunoblots of total brain lysates of
these mice (Supplementary Fig. 2h, red arrowhead). These
in vivo results together with the cell culture observations
establish that autophagy is altered at multiple stages,
leading to neuronal and axonal degeneration of both
cortical as well as spinal cord α-MNs (Supplementary Fig.
2a, f, g).
P56S-VAPB aggregation leads to altered distribution of
other fALS-associated RBP
Efficient turnover of several fALS-associated RBPs such
as TDP-43, FUS and of other RNA SGs is regulated by
UPS and autophagy54,55. Similarly, alterations of RBP
homeostasis can directly affect proteostasis (reviewed in
Fig. 3 P56S-VAPB alters early steps of autophagy. a Co-labelling of wt-VAPB and P56S-VAPB transfected HeLa cells with ULK1 showing co-
localisation with wt-VAPB. Note the reduction as well as the sequestration of ULK1 (arrows; merged middle and lower images) with P56S-VAPB
aggregates. Scale bar: 10 µm. b Sequestration of ATG5-ATG12 (arrows) with P56S-VAPB aggregates in HEK-293 cells Scale bar: 10 µm. c Filter trap assay
of the above transfected cells, showing SDS resistant aggregates of ULK1 and ATG5-ATG12 in P56S-VAPB expressing cells. d, e Immunoblot analysis
showing gel top aggregation (red arrowheads) as well as reduced soluble levels of ULK1 together with increased levels of LC3-II in P56S-VAPB
overexpressing HEK-293 cells (d) and in HeLa cells (e). Note the gel top aggregation (red arrowheads) of ATG5-ATG12 complex in P56S-VAPB
overexpressing cells as well as increased levels of ULK1 in wt-VAPB overexpressing cells. Unpaired Student’s t test for comparison between two
sample groups Values were expressed as mean ± standard error of mean (SEM) from three independent experiments. The asterisks denote significant
differences (*p < 0.05, ***p < 0.001). f Immunoblot analysis of NSC-34 cells showing increased levels of LC3-II and p62 in P56S-VAPB expressing NSC-
34 motor neuron-like cells. Unpaired Student’s t test for comparison between two sample groups Values were expressed as mean ± standard error of
mean (SEM) from three independent experiments. The asterisks denote significant differences (*p < 0.05). g Immunoblot analysis (quantification
below) showing concentration dependent increased levels of LC3-II and p62 in P56S-VAPB overexpressing cells compared to the wt-VAPB expressing
HeLa cells. Graph pad prism, One-way ANOVA, values were expressed as mean ± standard error of mean (SEM) from three independent experiments.
The asterisks denote significant differences (*p < 0.05, ***p < 0.001).
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Walsh et al.56). Since P56S-VAPB aggregates were asso-
ciated with impaired autophagy, we asked whether P56S-
VAPB-mediated toxicity is also linked to the altered dis-
tribution RBPs, in particular the key ALS proteins TDP43,
FUS and Matrin 3. These proteins normally reside in the
nucleus; in ALS, they often accumulate in the cytoplasm
of affected neurons1,26,29. We found that P56S-VAPB
aggregates are associated with loss of nuclear localisation
and cytoplasmic accumulation of above mentioned RBPs
(Fig. 5a–c) compared to the wt-VAPB transfected cells,
where they remained in the nucleus (Fig. 5a–c; upper
panels). In many instances, P56S-VAPB was partially co-
localised with some of these cytoplasmic RBP aggregates
(Fig. 5a–c). In line with this, subcellular fractionation
performed on P56S-VAPB expressing cells further con-
firmed the elevated protein levels of TDP-43, FUS and
Matrin 3 in the cytoplasmic fractions (Fig. 5d, red
arrowheads). Accordingly, there was mild to moderate
loss of nuclear localisation combined with diffuse cyto-
plasmic accumulation of pTDP-43 and Matrin 3 in α-
MNs of P56S-VAPB compared to wt-VAPB Tg mice
(Fig. 5e). Even though cytoplasmic FUS accumulations
were rather rare, loss of nuclear FUS was prominent in the
α-MNs of the P56S-VAPB mice (Fig. 5f). Prompted by
these observations, we further examined the ALS8 patient
muscle biopsy. Similar to the characteristic pTDP-43
aggregates found in sporadic and familial ALS α-MNs,
degenerating muscle fibres in this muscle biopsy displayed
accumulations of large globular pTDP-43 aggregates
(Fig. 5g). pTDP-43 aggregates can actually be seen in
atrophic and partially atrophic fibres of many sALS and
fALS autopsy cases57 (Supplementary Fig. 3d).
Fig. 4 Autophagy defects in P56S-VAPB transgenic mice. a Representative DAB immunohistochemistry (Left panel) and immunofluorescence
staining (right panel) using HA antibody in lumbar spinal cord α-MNs of wt and P56S-VAPB tg mice, showing globular aggregates in the α-MNs
(arrowheads) of P56S-VAPB tg mice. Scale bars: 15 µm. b, c Double immunofluorescence labelling for HA and for the autophagy marker LC3 (b) and
p62 lower panel showing co-localisation (arrowheads) with P56S-VAPB aggregates (c), and DAB immunohistochemistry showing globular
accumulations of p62 (arrows, upper panel) (c) in lumbar spinal cord α-MNs, Scale bars: 15 µm. d Immunoblot analysis of lumbar spinal cord
homogenates from P56S-VAPB (n= 6, male, 200 days) and their age-matched wt-VAPB mice (n= 3, male, 201 days), showing an overall increased
level of ER stress markers pIF2α and autophagy markers p62 and LC3 in P56S-VAPB tg mice. Corresponding densitometric data are shown at the
bottom; representing the average relative band intensity from n= 3 wt-VAPB and n= 6 P56S-VAPB of p62, LC3-II/LC3-I normalised with tubulin
levels. Unpaired Student’s t test for comparison between these two sample groups (average, n= 3 wt-VAPB mice and average, n= 6 P56S-VAPB
mice) Values were expressed as mean ± standard error of mean (SEM) from three independent blots. The asterisks (*) denote significant differences
(*p < 0.05). e–g Double immunofluorescence labelling for HA and for the SNARE protein STX17 (e), early autophagy proteins ULK1 (f) and ATG5-
ATG12 (g) showing their co-localisation (arrowheads) with P56S-VAPB aggregates in lumbar spinal cord α-MNs. Note the loss of STX17
immunoreactivity (arrows in e) in α-MNs harbouring P56S-VAPB aggregates in lumbar spinal cord of P56S-VAPB mice. Scale bars: 15 µm.
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Fig. 5 P56S-VAPB and altered distribution of other fALS-associated RBP. a–c Co-labelling of HeLa cells expressing wt-VAPB and P56S-VAPB with
antibodies against TDP43 (a) with FUS (b) and with Matrin 3 (c). Note that the cytoplasmic aggregation (arrowheads) and reduced nuclear
immunoreactivity (arrows) of these RBPs in P56S-VAPB expressing cells. Scale bar: 10 µm. d Immunoblot analysis of the subcellular fractions obtained from
HeLa cell expressing wt-VAPB and P56S-VAPB. Note the increased levels of TDP-43, FUS and of Matrin 3 (red arrowheads) in cytoplasmic extract (CE). ME
membrane extract, NE nuclear extract, CB chromatin bound, PE cytoskeleton. e DAB immunohistochemistry using antibodies against pTDP-43 and Matrin
3, showing altered nuclear immunoreactivity (black arrows) and diffuse albeit increased cytoplasmic immunoreactivity (white arrows) in lumbar spinal cord
α-MNs of P56S-VAPB tg mice. Scale bars: 15 µm. f Double immunofluorescence labelling for HA and for FUS antibodies showing reduced labelling of FUS
(arrow) in lumbar spinal cord α-MNs of P56S-VAPB tg mice. Scale bars: 15 µm. g Prominent and globular pTDP-43 immunoreactivity (white arrows- upper
panel; DAB, lower panel; immunofluorescence) of grouped angular or flattened, atrophic, denervated muscle fibres in the ALS8 biopsy. Scale bars: 80 µm.
h Co-localisation of globular and aggregated pTDP43 with VAPB aggregates (white arrows) in the same biopsy. Scale bars: 60 µm. i DAB
immunohistochemistry of Matrin 3, showing increased immunoreactivity of the myonuclei (arrows) and mildly diffuse saromeric accumulations. Note the
basal myonuclei immunoreactivity of Matrin 3 in non-atrophic normal-sized fibres (left panel). Co-immunolabelling (lower panel) with pTDP-43 antibody
showed no co-localisation between Matrin 3 accumulations and pTDP-43 aggregates. Scale bars: 80 µm.
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Interestingly, these abundant pTDP-43 aggregates were
also found to be co-localised with globular VAPB aggre-
gates (Fig. 5h, arrows, right panels). As expected, Matrin 3
immunoreactivity of myonuclei of degenerating muscle
fibres were elevated (Fig. 5i), while the normal-sized fibres
showed mild labelling of the myonuclei (Fig. 5i; left panel).
A mild diffuse pattern of cytoplasmic Matrin 3 immu-
noreactivity was also observed in many degenerating
fibres (Fig. 5i); however, there were no obvious cyto-
plasmic aggregates of Matrin 3 in this biopsy and there
was no co-localisation with pTDP-43 aggregates (Fig. 5i).
P56S-VAPB accumulation leads to abnormal stress granule
formation
Since aggregation of the above mentioned RBPs mostly
proceeds through the SG pathway2,26,29,58,59, we next
examined SG formation in cells transfected with wt or
P56S-VAPB. Consistent with the mis-localisations of
many fALS-associated RBPs, we observed cytoplasmic
accumulation of TIAR-1 and G3BP SGs in P56S-VAPB
expressing cells (Fig. 6a, b). For further validations, we
used a well-studied cell line stably expressing the SG
protein G3BP38. We found that SG formation in P56S-
VAPB transfected cells started within 10 h, even before
P56S-VAPB aggregates were formed (15 h after transfec-
tion). These aggregates increased in number and size at
24 h (Fig. 6c, d). We could not observe any SG formation
in cells expressing wt-VAPB during the same period of
time, however at later time (36 h) we could observe minor
SGs in few cells (Fig. 6d). Considering that SGs are highly
dynamic structures and that persistent stress and mis-
folded protein aggregation lead to prolonged SG stability
and aggregation38,58,60, we next studied the dynamic
properties of SGs formed by P56S-VAPB using fluores-
cence recovery after photobleaching (FRAP) analysis to
measures the relative kinetics of SGs over the time course
of the experiment38,58,60. FRAP analysis of these G3BP-
SGs showed a slower recovery in P56S-VAPB expressing
cells compared rare SGs observed in cells expressing wt-
VAPB (Fig. 6e, f). The persistent accumulations of these
SGs were further confirmed by subcellular fractionation
showing that the SG protein TIAR1 accumulated in the
cytoplasmic fraction (Fig. 6g) in P56S-VAPB expressing
cells. In line with these cell culture observations, we
observed an increased albeit diffuse immunoreactivity
of TIAR1 in lumbar spinal cords α-MNs of P56S Tg
mice (Fig. 6h). Finally, we observed an enhanced
immunoreactivity of large granular TIAR-1-positive
SGs in ALS8 patient muscle biopsy (Fig. 6i, arrows).
Interestingly, these SGs were co-localised with VAPB
aggregates (Fig. 6j, arrowheads). In summary, consistent
with the deregulation of RBPs, the robust formation of
SGs is a predominant feature of P56S-VAPB-driven
pathology.
Discussion
Altered RBPs homeostasis and defective proteostasis are
key mechanisms triggering neurodegeneration in ALS1,26.
In the present study we asked if P56S-VAPB is involved in
these processes to initiates pathological cascades leading
to neurodegeneration.
We found accumulations of p62 and LC3 protein and of
their sequestration with P56S-VAPB aggregates in various
cell culture models, P56S-VAPB mouse, ALS8 patient
fibroblast and muscle biopsy (Figs. 1–4). Furthermore,
alterations in autophagy flux were confirmed in multiple
cell lines (Figs. 1–3). Consistent with this, we found
numerous autophagic vacuoles associated with ubiquitin-
positive accumulations in ALS8 patient muscle biopsy
(Fig. 1). These results are in line with recent reports of
P56S-VAPB accumulations in the autophagosome and
with the ubiquitin-positive inclusions in MNs of ALS8
knock-in mice that were accompanied by increased levels
of P62/SQSTM1 and LC324. Of note in line with the
recently described role of VAPB in ER-phagy61, we found
proliferated, expanded ER both in P56S-expressing cells
and in the P56S-VAPB patient muscle biopsy (Fig. 1 and
Supplementary Fig. 3e). Thus, it appears reasonable to
propose that ER-assisted autophagy dysfunction is an
early, central step of P56S-VAPB-mediated ALS pathol-
ogy. In this context it is important to mention that apart
from VAPB, mutations, several ER proteins including
SigR1, SIL1, HSPB1, HSPB8 and HSJ1 cause defects in ER
structure accompanied by autophagy impairment and
lead to familial neurodegenerative disorders including
motor neuron diseases62–68. In sALS, the above wild-type
proteins accumulate in surviving MNs in sALS and might
serve protective functions, as has been shown for SigR1
and SIL119,69,70.
VAPB interacts with ATG proteins and also facilitate
the recruitment and stabilisation of ULK1 and FIP200
puncta at the ER, which is crucial for autophagosome
formation14. Loss of VAPB and PTPIP51 (ER-mitochon-
dria tethering complex) loosens the ER-mitochondria
contacts and induces autophagic flux, whereas over-
expression of wt-VAPB and PTPIP51 tightens the ER-
mitochondria contacts and thus impairs autophagy20,21.
Thus, confirming normal VAPB is decisive for autophagy
process. Consistent with these reports, reduction of ULK1
protein levels as well as co-aggregation of ULK1 and
ATG5-ATG12 together with P56S-VAPB aggregates
depicted in Fig. 3 and in α-MNs of P56S-VAPB mice
(Fig. 4) suggests probably an alteration of the initial phase
of autophagy. However, the concomitant appearance of
significantly increased levels of LC3-II in multiple cell
lines overexpressing P56S-VAPB and detailed analysis of
autophagic flux using autophagy reporter cell lines con-
firmed that P56S-VAPB also impairs the fusion of
autophagosomes to lysosomes, which is a late autophagy
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step (Figs. 2 and 3). In this context it is important to note
that besides orchestrating initial steps of autophagy, ULK1
can also regulate late steps of autophagy by promoting
autophagosome to lysosome fusion71.
RBPs including many SGs are particularly susceptible to
aggregation due to the presence of both RNA-binding
domains and prion-like domains, which contribute
strongly to aggregate formation under stressful stimuli
including chronic autophagy impairment72,73. In addition,
loss of dynamic nature of these SGs together with their
impaired clearance could results in the formation of
aberrant and persistent pathological inclusions2,38,58,74–76.
Notably, P56S-VAPB mice show signs of TDP-43
pathology23. Furthermore, the expression of P56S-VAPB
enhanced TDP-43-induced neuronal cell death in vitro,
whereas the expression of wt-VAPB attenuated neuronal
death77. Consistent with this, we found that P56S-VAPB
leads to neuronal cell death in iPSC-derived MNs (Sup-
plementary Fig. 1k) and a loss of nuclear localisation and
cytoplasmic aggregation of fALS-associated RBPs such as
FUS, TDP-43 and Matrin 3 and that of SGs in cultured
cells, P56S-VAPB mice, and in ALS8 patient muscle fibres
(Figs. 5 and 6). Additionally, supporting the notion that
RBP homeostasis largely relies on efficient autophagy,
here we confirmed that chemical inhibition of autophagy
leads to extra-nuclear localisation of the majority of fALS-
associated RBPs (Supplementary Fig. 3) similar to the
autophagy defects mediated by P56S-VAPB.
The ALS8 patient muscle biopsy presented can be
regarded as a missing piece of the puzzle. On one hand,
this is valuable human tissue, because α-MNs from P56S-
VAPB patients could not be examined so far because of
the lack of autopsy cases. On the other hand, the con-
siderable build-up of pTDP-43 in ALS8 muscle fibres
associated with VAPB aggregates is suggestive of primary
muscle involvement. This is in agreement with the
emerging concept that skeletal muscle pathologies in
MNDs are more than just a bystander and can actually
contribute to MN degeneration (reviewed in refs. 33,78).
Such primary muscle fibre damage is also suggested by
the presence of characteristic pTDP-43 aggregates in
sALS muscle biopsies (Supplementary Fig. 3b), confirm-
ing earlier studies using sALS autopsy muscle57. This
notion may also explain why the P56S-VAPB tg mice
published so far (also included in this study), which
express P56S-VAPB exclusively in the CNS, show only
minor degeneration of the neuromuscular axis.
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